Press Releases Statement: Inspector General’s Decision To Investigate FDA’s Inappropriately Close Collaboration With Biogen on the Alzheimer’s Disease Drug Aducanumab Is Long Overdue August 4, 2021
Press Releases Federal Agencies Must Investigate Serious Regulatory, Ethical Lapses in Reckless Epilepsy Clinical Trial Funded by NIH June 8, 2021
Letters, Testimony & Filings Letter to the OHRP and FDA Calling for Investigations into Serious Regulatory and Ethical Lapses in a Reckless Seizure Clinical Trial Funded by NIH June 8, 2021
Letters, Testimony & Filings Letter to the NIH Regarding Serious Regulatory and Ethical Lapses in a Reckless Seizure Clinical Trial Funded by the Agency June 8, 2021
Press Releases Statement: FDA Must Demand a New Clinical Trial of Experimental Alzheimer’s Disease Treatment Following Inappropriate Collaboration January 29, 2021
Press Releases Federal Regulators’ Failure to Act Endangered CLOVERS Trial Patients After Alarming Design Flaws, Ethical Lapses Were Identified October 13, 2020
Letter to OHRP Calling for Additional Agency Actions to Address Alarming Ethical and Regulatory Lapses in NIH-Funded Sepsis Clinical Trial October 13, 2020
Public Citizen Sues FDA for Failing to Respond to Petition to Ban Surgical Device Seprafilm August 27, 2020
Press Releases NIH Agrees With Public Citizen, Will Conduct Preclinical Trials of the Potential COVID-19 Treatment GS-441524 August 24, 2020